Skip to main content
Sun Pharmaceutical Industries Ltd. logo

Sun Pharmaceutical Industries Ltd. — Investor Relations & Filings

Ticker · SUNPHARMA ISIN · INE044A01036 LEI · 335800KJ7GE29LB4SS73 BSE.NS Manufacturing
Open in API
Filings indexed 1,411 across all filing types
Latest filing 2025-07-04 Annual Report
Country IN India
Listing BSE.NS SUNPHARMA

About Sun Pharmaceutical Industries Ltd.

https://sunpharma.com/

Sun Pharmaceutical Industries Ltd. is a global leader in specialty generic pharmaceuticals, focused on developing, manufacturing, and marketing a comprehensive range of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company’s extensive portfolio covers diverse therapeutic segments, including cardiology, psychiatry, neurology, gastroenterology, ophthalmology, dermatology, and orthopedics. It provides high-quality, affordable medicines across more than 100 markets worldwide, serving both chronic and acute care needs. A significant emphasis is placed on research and development to produce complex generics and innovative specialty products. The organization maintains a robust global manufacturing footprint, operating facilities that comply with stringent international regulatory standards. Its offerings encompass generics, branded generics, specialty medications, and over-the-counter products, aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2024-25 and the Notice of 33rd Annual General Meeting' and is from Sun Pharmaceutical Industries Limited. It explicitly states it is the Annual Report for the financial year 2024-25. The content includes detailed sections such as Corporate Overview, Statutory Reports, Financial Statements, Chairman and Managing Director’s Message, Key Performance Indicators, Ten Year Financial Highlights, and other comprehensive financial and operational data. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of detailed financial statements and management discussion confirms it is the official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K).
2025-07-04 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short announcement from Sun Pharmaceutical Industries Limited regarding the closure of the trading window in compliance with the company's Code of Conduct for Prohibition of Insider Trading. It specifies the period of closure related to the upcoming unaudited financial results for the quarter ended 30 June 2025. There is no actual financial data, detailed report, or presentation included. The document is an announcement about a procedural compliance matter ahead of a financial results release, not the results or report itself. The length is only 1285 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-06-26 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-06-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the schedule of upcoming analyst/institutional investor meetings. It does not contain financial results, detailed reports, or audit information. It is a regulatory announcement about a meeting schedule, not a report or transcript. The document is short (1672 characters) and serves as a notification to the stock exchanges and investors about the meeting schedule. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-06-24 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release from Sun Pharmaceutical Industries Limited regarding an update from their partner Philogen on the Marketing Authorization Application (MAA) for Nidlegy™ in the European Union. It discusses the voluntary withdrawal of the MAA and provides detailed background on the drug, clinical trials, and company information. There are no financial statements, earnings data, or regulatory filings such as annual or quarterly reports. The document is an announcement of a corporate development related to a product and regulatory status, not a financial report or management discussion. It fits best under the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit other more specific categories like Earnings Release or Annual Report. The document length is sufficient and contains substantive information, but it is not a financial report or management report. Therefore, the classification is RNS with high confidence.
2025-06-24 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement informing about the completion of a US FDA inspection at the company's Halol facility, mentioning the issuance of a Form-483 with observations. It is dated 14 June 2025 and addressed to stock exchanges. The content is regulatory in nature, providing an update on a regulatory inspection and its outcome. The document length is only 1189 characters, indicating it is a brief announcement rather than a detailed report. There are no financial statements, management discussion, or detailed audit information. It does not fit into categories like Annual Report, Audit Report, or Legal Proceedings Report since it is not a full report or detailed legal update. It is not a report publication announcement since it does not mention any report being published or attached. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance updates that do not fit other specific categories.
2025-06-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.